A Study of TCD601 in de Novo Renal Transplant Recipients

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

December 28, 2023

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Renal Transplantation
Interventions
BIOLOGICAL

TCD601

Investigational Product

BIOLOGICAL

belatacept

Study Product

DRUG

ATG

Comparator

DRUG

TAC

Comparator

DRUG

MPA

Immunosuppression Therapy

DRUG

Corticosteroids

Immunosuppression Therapy

Trial Locations (27)

10029

Mount Sinai Hospital, New York

10065

Weill Cornell Medicine, New York

19104

University of Pennsylvania, Philadelphia

22042

Inova Fairfax Hospital Medical Campus, Falls Church

22903

University of Virginia Health, Charlottesville

University of Virginia Hospital, Charlottesville

27157

Atrium Health Wake Forest Baptist Medical Center, Winston-Salem

29425

Medical University of South Carolina, Charleston

30322

Emory University Hospital, Atlanta

33606

Tampa General Hospital, Tampa

45219

University of Cincinnati Medical Center, Cincinnati

48109

University of Michigan Health System, Ann Arbor

48202

Henry Ford Hospital, Detroit

55905

Mayo Clinic, Rochester

60153

Loyola University Medical Center, Maywood

60611

Northwestern University, Chicago

63110

Washington University in St. Louis (Barnes-Jewish Hospital), St Louis

66160

University of Kansas Medical Center, Kansas City

68198

University of Nebraska Medical Center, Omaha

70121

Ochsner Clinic Foundation, New Orleans

77030

Houston Methodist Hospital, Houston

78229

UT Health San Antonio, San Antonio

90033

University of Southern California, Los Angeles

92037

Scripps Green Hospital, La Jolla

94143

University of California San Francisco Medical Center, San Francisco

95817

University of California Davis Medical Center, Sacramento

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

ITB-Med LLC

INDUSTRY

NCT05669001 - A Study of TCD601 in de Novo Renal Transplant Recipients | Biotech Hunter | Biotech Hunter